Ana María Gómez Medina, Colombia
Hospital Universitario San Ignacio Endocrinology UnitPresenter of 1 Presentation
VIRTUAL TRAINING ON THE HYBRID CLOSE LOOP SYSTEM IN PEOPLE WITH TYPE 1 DIABETES (T1D) DURING THE COVID-19 PANDEMIC.
Abstract
Background and Aims
As a technology-focused diabetes care center, we developed a virtual training program for patients with type 1 diabetes (T1D) who were upgrading to the hybrid closed-loop (HCL) system after mandatory isolation during the COVID-19 pandemic. We aim to describe outcomes of a virtual training program and compare the manual mode against the auto mode feature.
Methods
A prospective observational cohort study. Patients with diagnosis of T1D previously treated with multiple doses of insulin (MDI) or sensor augmented pump therapy (SAP) who were updating to Hybrid Close loop (HCL) system from March to July 2020, were included. The education program consisted in at least seven sessions according to baseline therapy. Virtual training and follow-up were done through the Zoom video conferencing application and Medtronic Carelink System version 3.1 software. Demographical, clinical and A1c data were collected. CGM data such as TIR, time below range (TBR), time above range (TAR) and coefficient of variation (%CV) after two weeks using manual mode and the last two weeks in auto mode were analyzed.
Results
91 patients were included in the analysis. Mean TIR achieved with manual mode was 77.3 ±11.3%. A significant increase in TIR to 81.6% ± 7.6% (p <0.001) was described after two weeks of auto mode use with a significant reduction in TBR<70mg/dL from 2,7%±2,28% to 1,83%±1,67% (p<0,001). Reduction of glycemic variability was significant independent of baseline therapy.
Conclusions
Virtual Training and follow-up through the Carelink platform allows the achievement of adequate results similar to face-to-face training.